{"name":"Werewolf Therapeutics, Inc.","slug":"werewolf-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":44830000,"netIncome":-60822000,"cash":57050000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPeFNfRm45ZE9QY3N1NTJqYnd5WnRZQjNHM1pSQ1F4YWhDRFZxTVE4c2VfNkEwVUJfVzY1WW8tb2pMcDIwcjUyLUVUZ1ZQeXFwdlZoRUMtV3d1SlVXUDFpSXhpYzlYQmE5TllXQ0syaWlOdjZ0SXAzTHNQYnJibkU2bUNUYW11R00wY3gwVmtHcERUVFkxYy0wR2xEMUpqTXhYNWVrNlNDMFVxSnRWeDBNdTZ3?oc=5","date":"2026-03-27","type":"pipeline","source":"Stock Titan","summary":"Werewolf Therapeutics (HOWL) faces going‑concern risk while IL‑2 and IL‑12 candidates show early responses - Stock Titan","headline":"Werewolf Therapeutics (HOWL) faces going‑concern risk while IL‑2 and IL‑12 candidates show early responses","sentiment":"neutral"},{"date":"2026-03-27","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-24","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNYmJNNzVtVTZHUS1UcExuUUttREVkVjhFZ3JOcl93ZjZWMWVrU0ZIOVN0dUFBNEEtU0RLdzhTQTU2WkVUSzJmaDlOTTRNU3dzX3VkS1dWd3VwaEJIcGh3XzFOOUhxby1rei1xM1NZaEt2YUhmZnVqZE9hTDdaTGllQ18wRW4tRHdadUlRRk53cUpHQQ?oc=5","date":"2025-12-18","type":"pipeline","source":"Investing News Network","summary":"Werewolf Therapeutics Announces Pipeline and Business Updates - Investing News Network","headline":"Werewolf Therapeutics Announces Pipeline and Business Updates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQQWF4bjBGZURZNXMyM2dVMGl2eURNclVlcUFjbFpxXy1TLV9mb0Myc1lhTFlUVG9lSm1YaEd5bkFSN3dReGtLRkFGaHdWQ3EtQWNYTzJOTnNOSFlSTVE2UVF4LXNab0s2V1ZtVzl4WHBpN2ctY0lQVGhBQUFCb1JtM1IySjFmaDlLQ2ZCYVhfQms5RTIzVXo2RXA4R2plVF9mYlBF?oc=5","date":"2025-11-04","type":"regulatory","source":"Oncology News Central","summary":"Oncology Drugs Fast-Tracked by the FDA in October 2025 - Oncology News Central","headline":"Oncology Drugs Fast-Tracked by the FDA in October 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPUkgwTU44VmtGSFM2SHJCU3Y2WGlnQnAtV3pFS1lWaVFJWDNlMzZKNVJHSWxydUw5Rk8wX2xyYUhWeDAteFUzSW1oTmhHQjV1aTRsZ3JKM0FOYWNEbU1zc216RjlpOHhGblBFUXQtRTdkb3ZkVE9Cd2l4M0E2bkR1SmFocVJNT1ZFOHpsN1dvSjBKYU14TUljRQ?oc=5","date":"2025-09-29","type":"pipeline","source":"Pharmaceutical Technology","summary":"The dangerous second life of medical waste - Pharmaceutical Technology","headline":"The dangerous second life of medical waste","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOR2lGcGZfb3FYWjRaTUhsQnZuZFlTaUJUU2xwY2l1MWtEdWFNQWV1eVhTNnlZejdRbUsxazZlcXJERUdTVGd0bmIzS0hMTmt4RDRUQWc4TlE2ODh3TjFncHprbHFRbmZrOXpmVUhkY1JHT0FadmNOTElZU2Z5UlRaSkdQMlhNQjVLQzBHYWpFY0RjVW9rSnZMQUtHV09tVkZVazMxRzlwdnZ3TzAxeXEtWQ?oc=5","date":"2025-07-28","type":"pipeline","source":"Contract Pharma","summary":"ReAlta Life Sciences Names Ellen Lubman as Chief Business Officer - Contract Pharma","headline":"ReAlta Life Sciences Names Ellen Lubman as Chief Business Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFBrNGQtc0R6NFRxY01tamRGMllGZGZTZUtDTkZSaUFtRlVMdXdDQXFUSUJJZVdXN1d2ZUZmZmJibi00Q2FFdDdaVjJCU3J3UWktRjZHMW1DVXhXZ1lYVXNYU1VmZ0tEXzRZ?oc=5","date":"2025-07-09","type":"regulatory","source":"MarketBeat","summary":"Werewolf Therapeutics (HOWL) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat","headline":"Werewolf Therapeutics (HOWL) FDA Approvals, PDUFA Dates & Drug Alerts 2026","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTFBwcW95ckNFV2I0TkctOEstaThLbGliNV9scldadTBwWjhNY0JKdFl3M2xUeWxlSHFzRTFBMUF0WDRmMWo1Vmx4TUZ1WDRYSmpW?oc=5","date":"2023-11-03","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE5oNmUybDFEc1FCTUNWZEcyRXRuUk1QUzYwelhXQnJuaFFfUWRJemdkZkNtb3JiSXVQNHZ4ZncwSVRBS1BnRzdvYm5JOWw3X21LRGx5Ul9hRFRGTlk5?oc=5","date":"2022-05-03","type":"pipeline","source":"TradingView","summary":"HOWL Stock Price and Chart — NASDAQ:HOWL - TradingView","headline":"HOWL Stock Price and Chart — NASDAQ:HOWL","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AJBVV95cUxORlotWFB3aVNiVjdFcWZHU0FoX0V4aWduMlpib1NQQ3RrTmpZMGZLMFVaNGJCdHJ6Sml4UUpoYWxoNkVVRk44Tzk1aDhFWDJjX2lYaWdCaXlPTm1QUE9hVUZ2dzUzREc1eUNqT2xWaExYenRLRWdjYjVXakxqQ3BEVzNTM0dKR2RHM3hNYUtlYVhqWGFBamV6VWNrZXBxWm5kcDYxcVVaODdhNmM0bWtrcGpmUzBieS1KWEtuMmc4VDQ4Tk1FS0VSRDRiY2p5SU1scFJ1SFV4OFVFcGV0aXI4Y0FrM2VTaDhjNGxoM2RoVjBfU2VDaWY4TVN3bVJwcDVydklfZUd1UnJkU2FCMHFEYThiSkdtSTM5RndhM25XVFQtRTJBSGNoZ1RkODh4azN5cVVBbWpTQjV3SlkwX2RSQ0RhLWFpS2ZHQWMtU0VnMmE1aHE3ZUpCS2FkWjJhcVN2RGxUVg?oc=5","date":"2022-04-07","type":"deal","source":"PR Newswire","summary":"Jazz Pharmaceuticals and Werewolf Therapeutics Announce Exclusive Global License and Collaboration Agreement to Develop WTX-613, a Differentiated, Conditionally-Activated IFNα INDUKINE™ Molecule - PR ","headline":"Jazz Pharmaceuticals and Werewolf Therapeutics Announce Exclusive Global License and Collaboration Agreement to Develop ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNajFIbGhoSmRLcVA5MnlGQUtuZWRhSV9rZm1KNDh0YjZFWVJDVUM2UHFoUXhOVk55UHc3RG5WbDVjbXUxdlRGdHZDMFdQVmlVc3lXUmk3aURCM05SZDdFQlVHVjNCR3NPVC1OS0tLNEZsWnZ3WUlRNHRhNDV2YmRKdXJLYVU1WWtRdHZLTzJiY2kzVi1xNHlmaDV0LTJDUldBSmZGMzJlSEFaUENncnQydTFTZw?oc=5","date":"2022-04-07","type":"deal","source":"MedCity News","summary":"Werewolf cancer drug strikes right note with Jazz Pharma, sparking licensing deal - MedCity News","headline":"Werewolf cancer drug strikes right note with Jazz Pharma, sparking licensing deal","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":44830000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-60822000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":57050000,"cashHistory":[],"totalAssets":69396000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}